Page 5 - Best Prostate cancer doctors: TOP 145 doctors

Prof. Arie Lindner heads the Urology Department at Assaf Harofeh Medical Center, specializing in complex prostate surgeries.

• Trained at UCLA's urology program in Los Angeles
• Expert in laser treatments for prostate conditions
• Member of American, European & Israeli urology associations
• Chairman of Israel's Trade Union of Doctors

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Vladimir Yutkin brings over 30 years of experience of medical expertise to his practice at Hadassah Medical Center.

• Graduated from the Faculty of Medicine at Hebrew University of Jerusalem
• Specializes in diagnosis and treatment of temporomandibular joint disorders
• Fluent in English, Hebrew, and Russian for patient communication

Dr. Jablonski-Perec is a professor of oncology at the prestigious Hebrew University in Jerusalem, bringing senior academic expertise to prostate cancer care.

• Heads the Institute of Oncology at Hadassah Medical Center
• Fellowship-trained at Memorial Sloan Kettering Cancer Center in New York
• Holds the title of Professor from Hebrew University's medical school
• Member of several international oncology associations
• Awarded a scholarship from Hadassah Medical School

Head of the Department of Surgery at Hadassah Medical Center, specializing in colorectal cancer and surface malignancies.

• Extensive experience in surgical oncology
• Specialized focus on complex cancer cases
• Leads a top-tier surgical department

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Professor Gofrit leads the Urology Department at Hadassah Medical Center and is qualified in robotic surgery. He completed specialized training in invasive urology and oncology at the University Hospital of Chicago.

• Chief physician of Urology at Hadassah Medical Center
• Specializes in surgical treatment of bladder and prostate cancer
• Qualified to perform robotic surgeries using the da Vinci system
• Teaches urological surgery at Hebrew University
• Published numerous scientific papers on urology and oncology

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Serkan Deveci leads urology at Medical Park Göztepe, publishing 30+ research papers on prostate cancer outcomes.

• Specialized in robotic-assisted prostatectomy and nerve-sparing techniques
• Member of the American Urology Association and Turkish Urological Association
• Section Editor for UpToDate’s urology content – trusted by doctors worldwide
• 621 citations attest to his research impact in prostate cancer treatment

focusing on robotic urological surgery – Dr. Colombo combines precision with extensive experience at St. Zdislava Hospital.

• Specialized in robotic-assisted prostate cancer procedures
• Member of European & American Urology Associations
• Published 150 research papers in urology journals
• Graduated from Charles University Prague – one of Europe's oldest medical schools

Head of Samsung Department of Urology – Dr. Choi leads one of Korea's top urology teams.

• Specializes in prostate cancer surgery and treatment
• Oncosurgeon with extensive experience in urological cancers
• Works at Samsung Medical Center – a leading cancer hospital

Radiotherapy specialist at Nordwest Clinic – Dr. Van Kampen focuses exclusively on prostate cancer treatments.

• Specializes in advanced radiotherapy techniques
• Works at a leading urology center in Germany
• Dedicated to personalized treatment plans

Over 100 published scientific papers focusing on uro-oncology. Prof. Becht has of experience as a urologist in Germany.

• Chairs the 'Interdisciplinary Urooncology Frankfurt' association
• Specializes in minimally invasive treatment of prostate cancer
• Holds an honorary doctorate from the Kapodiastrias University of Athens
• Lectures at Goethe University in Frankfurt am Main

Urologist, Surgeon

Heads the oncological surgery department at Rabin Medical Center and leads advanced clinical studies in oncourology.

• of experience as a specialist oncologist and oncourologist
• Specializes in urological tumors like prostate, kidney, and bladder cancer
• Head of numerous international clinical experimental research trials
• Active speaker and participant at international oncology forums

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Lo Zhunchen brings over of medical expertise to prostate cancer care at Fuda Cancer Hospital.

• Specializes in Internal Medicine, Respiratory Medicine, and Clinical Hematology
• Experienced in chemotherapy and radiotherapy treatments
• Focuses on patient comfort and satisfaction
• Committed to evidence-based medicine and patient education